Social, Financial Factors Tied to VTE Anticoagulant Use
Physicians are less likely to prescribe recommended oral anticoagulants to patients facing housing insecurity or financial barriers, according to a Michigan Medicine study.
Physicians are less likely to prescribe recommended oral anticoagulants to patients facing housing insecurity or financial barriers, according to a Michigan Medicine study.
Physicians are less likely to prescribe recommended oral anticoagulants to patients facing housing insecurity or financial barriers, according to a Michigan Medicine study.
Read MoreA study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
Read MoreA clinical trial found that minimally invasive endovascular therapy reduces symptoms of post-thrombotic syndrome after deep vein thrombosis.
Read MoreThe American Heart Association and American College of Cardiology issued their first joint clinical practice recommendations for acute pulmonary embolism.
Read MoreScientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving certain COVID‑19 vaccines, or after natural adenovirus infection.
Read MoreThe ADLM issued guidance for coagulation testing in patients using direct oral anticoagulants (DOACs), including stroke, deep vein thrombosis, and pulmonary embolism.
Read MoreResearchers caution that COVID-19 history is an “additional risk factor” for VTE in patients undergoing panniculectomy to remove excess abdominal skin.
Read MoreA study of over 4,000 children found an unexpectedly high frequency of pulmonary embolism—equal to rates seen in adults.
Read MoreSonoVascular Inc’s SonoThrombectomy System is a catheter-based system that delivers ultrasound energy, microbubbles and thrombolytic drug to break down blood clots via an integrated mechanical-pharmacological approach.
Read MoreAn NBA all-star for the Milwaukee Bucks will miss the remainder of the NBA regular season after being diagnosed with deep vein thrombosis (DVT).
Read MoreCardiorespiratory specialists warn discuss warning signs for pediatric emboli, which are on the rise, they say.
Read MoreGreater exposure to long-term air pollution was linked with increased risks for venous thromboembolism — blood clots that can occur in deep veins.
Read MoreThe San Antonio Spurs report center Victor Wembanyama has been diagnosed with deep vein thrombosis (DVT) in his shoulder and will miss the rest of the NBA’s regular season.
Read MoreArgon Medical Devices has enrolled the first patient in a US-based study exploring a novel catheter-based device for managing blood clots in the lungs.
Read MoreThe likelihood of VTE was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Read MoreThe clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Read MoreThe trend of hospitalizing low-risk PE patients continues despite evidence supporting safe outpatient care, according to a new analysis.
Read MoreNew research shows an endovascular catheter, recently approved by the FDA and already shown to be effective in reducing blockages in lung arteries, also reduces blockages in the smaller segmental pulmonary artery branches.
Read MoreDespite advancements, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years—more often killing men, Black patients, and those from rural areas.
Read MoreModern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45% compared to the traditional drug warfarin in the treatment of blood clots in the lungs and legs, according to a new long-term study.
Read MoreED patients with congestive heart failure and dyspnea are less likely to be tested for pulmonary embolism when their ED forms specifically mention CHF instead of “shortness of breath.”
Read MoreA modeling study suggests that continuing anticoagulation therapy indefinitely, which is recommended in all patients with a first unprovoked venous thromboembolism, has little chance of improving life expectancy and is unlikely to ever be cost-effective.
Read MoreA new study suggests CT results alone may not confer as much risk as traditionally thought—a finding that will come as a surprise to most emergency physicians, according to one of the study’s authors.
Read MoreSleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours of sleep.
Read More